PBE vs BVAL
Comparison between INVESCO BIOTECHNOLOGY & GENOME ETF (PBE, ETF) and BLUEMONTE LARGE CAP VALUE ETF (BVAL, ETF).
5-Year PerformanceBVAL has outperformed PBE, delivering a return of +12.4% compared to +5.4%
PBE vs BVAL - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
PBE vs BVAL - Holdings Comparison
PBE and BVAL have 1 common holdings. Overlap is 0.00%
PBE's top 25 holdings weight is 90.34%. BVAL's top 25 holdings weight is 99.84%.
| Rank | PBE | BVAL |
|---|---|---|
| #1 | REGENERON PHARMACEUTICALS INC (REGN) - 5.46% | SPDR® PORTFOLIO S&P 500 VALUE ETF (SPYV) - 34.35% |
| #2 | AMGEN INC (AMGN) - 5.41% | SCHWAB US LARGE-CAP VALUE ETF„¢ (SCHV) - 29.29% |
| #3 | VERTEX PHARMACEUTICALS INC (VRTX) - 5.19% | VANGUARD RUSSELL 1000 VALUE ETF (VONV) - 19.58% |
| #4 | CAREDX INC (CDNA) - 5.00% | SPDR® PORTFOLIO S&P 500® ETF (SPLG) - 15.63% |
| #5 | ROYALTY PHARMA PLC CLASS A (RPRX) - 4.74% | CASH (n/a) - 0.91% |
| #6 | BIOGEN INC (BIIB) - 4.71% | INVESCO RAFI US 1000 ETF (PRF) - 0.05% |
| #7 | GILEAD SCIENCES INC (GILD) - 4.59% | THE GOLDMAN SACHS GROUP INC (GS) - 0.01% |
| #8 | UNITED THERAPEUTICS CORP (UTHR) - 3.83% | ISHARES CORE S&P 500 ETF (IVV) - 0.01% |
| #9 | PROTAGONIST THERAPEUTICS INC (PTGX) - 3.67% | THE HOME DEPOT INC (HD) - 0.01% |
| #10 | HALOZYME THERAPEUTICS INC (HALO) - 3.56% | ALPHABET INC CLASS A (GOOGL) - 0.00% |
| #11 | BIO-TECHNE CORP (TECH) - 3.51% | AMERICAN ELECTRIC POWER CO INC (AEP) - 0.00% |
| #12 | OMEROS CORP (OMER) - 3.44% | ALTRIA GROUP INC (MO) - 0.00% |
| #13 | REPLIGEN CORP (RGEN) - 3.37% | APPLIED MATERIALS INC (AMAT) - 0.00% |
| #14 | ACADIA PHARMACEUTICALS INC (ACAD) - 3.31% | AT&T INC (T) - 0.00% |
| #15 | ALNYLAM PHARMACEUTICALS INC (ALNY) - 3.31% | AVANTIS US EQUITY ETF (AVUS) - 0.00% |
| #16 | ILLUMINA INC (ILMN) - 3.02% | AMAZON.COM INC (AMZN) - 0.00% |
| #17 | INCYTE CORP (INCY) - 2.97% | BANK OF AMERICA CORP (BAC) - 0.00% |
| #18 | BIOMARIN PHARMACEUTICAL INC (BMRN) - 2.96% | ALLIANZIM US LRG CP 6M BFR10 JUN/DEC ETF (SIXD) - 0.00% |
| #19 | VERICEL CORP (VCEL) - 2.95% | BP PLC ADR (BP) - 0.00% |
| #20 | QIAGEN NV (QGEN) - 2.78% | BROADCOM INC (AVGO) - 0.00% |
| #21 | BIOCRYST PHARMACEUTICALS INC (BCRX) - 2.67% | CAPITAL GROUP DIVIDEND VALUE ETF (CGDV) - 0.00% |
| #22 | SAREPTA THERAPEUTICS INC (SRPT) - 2.52% | CAPITAL GROUP GROWTH ETF (CGGR) - 0.00% |
| #23 | PTC THERAPEUTICS INC (PTCT) - 2.51% | CAPITAL GROUP INTERNATIONAL FOCUS EQ ETF (CGXU) - 0.00% |
| #24 | EXELIXIS INC (EXEL) - 2.48% | APPLE INC (AAPL) - 0.00% |
| #25 | ANAPTYSBIO INC (ANAB) - 2.38% | CAPITAL GROUP NEW GEOGRAPHY EQUITY ETF (CGNG) - 0.00% |
| Total Holdings | 33 | 200 |
PBE vs BVAL - Historical Returns
Returns include dividend reinvestment.
PBE vs BVAL - Annual Returns (2005 - 2026)
Returns include dividend reinvestment.
| Year | PBE | BVAL |
|---|---|---|
| 2026 | +21.18% | +15.91% |
| 2025 | +23.76% | +11.37% |
| 2024 | -0.05% | N/A |
| 2023 | +4.60% | N/A |
| 2022 | -11.11% | N/A |
| 2021 | +1.21% | N/A |
| 2020 | +25.68% | -10.34% |
| 2019 | +18.35% | +27.16% |
| 2018 | -2.62% | -9.48% |
| 2017 | +20.54% | +6.96% |
| 2016 | -20.66% | N/A |
| 2015 | +1.36% | N/A |
| 2014 | +36.45% | N/A |
| 2013 | +57.53% | N/A |
| 2012 | +13.17% | N/A |
| 2011 | -7.24% | N/A |
| 2010 | +29.99% | N/A |
| 2009 | +19.16% | N/A |
| 2008 | -25.84% | N/A |
| 2007 | +6.24% | N/A |
| 2006 | +0.45% | N/A |
| 2005 | +17.45% | N/A |
PBE vs BVAL Drawdown Comparison
The maximum drawdown for PBE was -45.69%, occurring on Mar 9, 2009. Recovery took 644 trading sessions.
The maximum drawdown for BVAL was -37.18%, occurring on Mar 23, 2020. Recovery took 118 trading sessions.
The current BVAL drawdown is -0.68%.
| Rank | PBE | BVAL |
|---|---|---|
| #1 | -45.69% Oct 15, 2007 - May 6, 2010 | -37.18% Feb 12, 2020 - Jun 23, 2025 |
| #2 | -44.56% Jul 17, 2015 - Jul 20, 2020 | -15.50% Jan 26, 2018 - Apr 26, 2019 |
| #3 | -37.84% Feb 8, 2021 - Nov 26, 2025 | -6.69% Feb 26, 2026 - Apr 17, 2026 |
| #4 | -35.71% May 6, 2010 - Apr 2, 2013 | -6.25% Apr 30, 2019 - Jun 18, 2019 |
| #5 | -21.12% Feb 27, 2006 - Apr 23, 2007 | -6.19% Aug 8, 2017 - Nov 29, 2017 |
| #6 | -18.86% Feb 24, 2014 - Aug 25, 2014 | -6.05% Jul 29, 2019 - Oct 28, 2019 |
| #7 | -14.38% Jul 20, 2020 - Nov 27, 2020 | -3.96% Nov 12, 2025 - Nov 28, 2025 |
| #8 | -11.73% Jan 7, 2026 - Jun 23, 2026 | -3.89% Jan 17, 2020 - Feb 12, 2020 |
| #9 | -10.65% Mar 19, 2015 - Jun 18, 2015 | -2.79% Jul 25, 2025 - Aug 13, 2025 |
| #10 | -10.08% Sep 12, 2005 - Nov 17, 2005 | -2.71% Oct 6, 2025 - Oct 23, 2025 |
| #11 | -9.07% Apr 25, 2007 - Sep 26, 2007 | -2.30% Jun 4, 2026 - Jun 12, 2026 |
| #12 | -8.60% Aug 29, 2014 - Oct 23, 2014 | -2.24% Oct 27, 2025 - Nov 12, 2025 |
| #13 | -7.84% May 28, 2013 - Jul 5, 2013 | -1.88% Nov 27, 2019 - Dec 6, 2019 |
| #14 | -7.21% Nov 29, 2013 - Jan 7, 2014 | -1.72% Jun 19, 2017 - Jun 27, 2017 |
| #15 | -6.59% Oct 2, 2013 - Oct 24, 2013 | -1.63% Jan 15, 2026 - Jan 29, 2026 |
Correlation
Correlation between PBE and BVAL is 0.95 which considered as a very strong positive correlation - the stocks move almost identically together.
Dividend Comparison (2009 - 2026)
PBE vs BVAL dividend yield comparison.
| Year | PBE | BVAL |
|---|---|---|
| 2026 | 0.90% | 0.65% |
| 2025 | 1.00% | 0.73% |
| 2024 | 0.05% | 0.00% |
| 2023 | 0.02% | 0.00% |
| 2020 | 0.04% | 0.00% |
| 2019 | 0.00% | 1.17% |
| 2018 | 0.00% | 1.85% |
| 2017 | 0.57% | 0.80% |
| 2016 | 0.38% | 0.00% |
| 2015 | 1.12% | 0.00% |
| 2014 | 0.55% | 0.00% |
| 2009 | 0.45% | 0.00% |
Select Stocks to Compare
More Comparisons
Compare with similar stocks